Key Points HIV Infections and AIDS HIV Surveillance HIV lab participation is 100%: in Réunion, all laboratories participated Overall coverage of the DO is estimated at 92% in 2023 and...

Key Points HIV Infections and AIDS HIV Surveillance The two laboratories in Mayotte, one public (CHM) and the other private (Biogroup), participate in the LaboVIH survey, which...

Key Points HIV Infections and AIDS HIV Surveillance Participation in LaboVIH: Comprehensive In 2023, laboratory participation in the LaboVIH survey remains comprehensive, as it was in...

Key Points HIV Infections and AIDS Participation in HIV SurveysIn 2023, fewer laboratories participated in the LaboVIH survey (80% vs. 97% in 2022). However, mandatory reporting of HIV...

Key Points HIV Infections and AIDS HIV Surveillance Participation in LaboVIH continues to rise, reaching 95% Coverage of diagnostic testing in the Grand Est region, at 72%, has...

Key Points HIV Infections and AIDS Significant increase in the HIV testing rate, particularly among those aged 50 and older, with a major contribution from the VIHTest...

Key Points HIV Infections and AIDS HIV Surveillance: Participation in LaboVIH: comprehensive Since 2020, laboratory participation in the LaboVIH survey has remained...

Key Points HIV Infections and AIDS HIV Surveillance: Coverage of Diagnostic Testing and Participation in LaboVIH on the Rise HIV testing: Testing activity is increasing and positivity...

In 2023, an estimated 3,650 people were infected with HIV in France. This number has remained stable since 2021, following a long period of decline. Screening for HIV and bacterial...

Key Points A total of 209 cases of mpox have been reported to Santé publique France since January 1, 2024, including 6 in the last 14 days. Only clade II Monkeypox viruses have been...